The FLUENT study design: investigating immune cell subset and neurofilament changes in patients with relapsing multiple sclerosis treated with fingolimod.

Jeffrey A CohenAmit Bar-OrBruce A C CreeYang Mao-DraayerMay H HanBarry SingerAnn JannuScott KolodnyXiangyi MengRyan C Winger

Published in: Multiple sclerosis journal - experimental, translational and clinical (2019)

FLUENT may provide evidence for the use of immunologic profiling in predicting efficacy and risk of infection in patients with RMS treated with fingolimod.

Keyphrases

multiple sclerosis
white matter
single cell
newly diagnosed
systemic lupus erythematosus
genome wide analysis